US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.592
  • -0.028-4.52%
Trading Jan 10 15:45 ET
151.46MMarket Cap-3.54P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptimmune Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.300M--
--2024/Q4-- / 8.828M--
Nov 13, 20242024/Q340.901M / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.300M--
--2024/Q4-- / 8.828M--
Nov 13, 20242024/Q340.901M / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--

Unlock Free Earnings Estimates

Adaptimmune Therapeutics Earnings Reports

  • Adaptimmune Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:24 ET

  • Adaptimmune Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 07:26 ET

  • Adaptimmune Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15, 2024 22:23 ET

  • Adaptimmune Therapeutics | 10-K: FY2023 Annual Report

    Mar 6, 2024 07:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 10, 2025

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday-0.58%